263 Up regulation of PD-L1 on peripheral blood CD3+ T cells predicts poor prognosis in patients with non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) inhibitors. (September 2015) - Meniawy, T.; Lake, R.; McDonnell, A.; Millward, M.; Nowak, A.